Gene: PI4KB
Official Full Name: phosphatidylinositol 4-kinase betaprovided by HGNC
Gene Summary: Enables 1-phosphatidylinositol 4-kinase activity and 14-3-3 protein binding activity. Involved in inner ear development. Acts upstream of or within lysosome organization. Located in Golgi membrane. Implicated in autosomal dominant nonsyndromic deafness 87. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO07943 | PI4KB Knockout cell line (HeLa) | Human | PI4KB | 1:3~1:6 | Negative | Online Inquiry |
KO07944 | PI4KB Knockout cell line (HCT 116) | Human | PI4KB | 1:2~1:4 | Negative | Online Inquiry |
KO07945 | PI4KB Knockout cell line (HEK293) | Human | PI4KB | 1:3~1:6 | Negative | Online Inquiry |
KO07946 | PI4KB Knockout cell line (A549) | Human | PI4KB | 1:3~1:4 | Negative | Online Inquiry |
PI4KB Gene Knockout Cell Lines are genetically modified cell lines specifically engineered to lack the PI4KB (Phosphatidylinositol 4-kinase beta) gene. This product serves as a crucial tool for researchers investigating the role of phosphoinositides in cellular signaling pathways and membrane trafficking. By disabling the PI4KB gene, these knockout cell lines facilitate the study of the resulting phenotypic and biochemical changes, allowing scientists to explore the implications of phosphatidylinositol metabolism in various biological contexts.
The key function of PI4KB gene knockout cell lines lies in their ability to elucidate the cellular mechanisms that involve phosphatidylinositides, which serve as pivotal signaling molecules involved in critical processes such as cell growth, differentiation, and cytoskeletal organization. Researchers can utilize these cell lines to analyze the downstream effects of PI4KB loss, including alterations in phosphoinositide levels and their corresponding impact on cellular processes like vesicular transport and apoptosis.
The scientific importance of these knockout cell lines is underscored by their myriad applications in both research and clinical settings, particularly within the fields of cancer biology, neurobiology, and metabolic disorders. By enabling targeted investigations into PI4KB's involvement in disease mechanisms, these cell lines can contribute to the identification of potential therapeutic targets and strategies.
Comparatively, PI4KB gene knockout cell lines offer significant advantages over existing alternatives, such as standard wild-type cell lines or those with incomplete knockdowns. They provide a clearer genetic background for molecular studies, which enhances experimental precision and reliability. Additionally, the well-characterized nature of these cell lines facilitates reproducibility, a critical factor in scientific research.
For researchers and clinicians, the availability of PI4KB gene knockout cell lines represents a valuable opportunity to unlock new insights into cellular signaling networks and disease pathology. By leveraging these advanced tools, professionals can enhance their research capabilities and accelerate the discovery of innovative therapeutic interventions.
Our company, with its commitment to providing high-quality biological products, leverages extensive expertise in genetic engineering and cell line development to offer these PI4KB gene knockout cell lines, equipping researchers with the sophisticated tools they need to advance their scientific inquiries.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.